Skip to content

Lumexa Imaging Holdings, Inc. LMRI Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

RadNet logo
RadNetRDNT
-$2.59M-545%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$59.33M
Opko Health logo
Opko HealthOPK
$34K-99.1%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$100K
Mirion Technologies logo
Mirion TechnologiesMIR
-$100K0.0%
Novanta logo
NovantaNOVT
$248K-94.3%

Other financials

Income statement

See full
Revenue$252.5M+3.1%
Operating income$19.4M-24.0%
Net income$1.7M+122%
EPS (diluted)$0.02+118%

Balance sheet

See full
Cash & equivalents$51.2M
Total debt$965.8M
Total equity$599.6M+272%
Total assets$1.8B

Cash flow

See full
Operating cash flow$2.9M+121%
CapEx$5.3M+431%
Free cash flow-$2.4M+84.1%

Valuation

See full
Market cap$1.02B-42.0%
Enterprise value$1.93B

Returns & leverage

See full
Debt / equity1.6×
Current ratio1.4×

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: Lumexa Imaging Holdings, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lumexa Imaging Holdings, Inc. 's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lumexa Imaging Holdings, Inc. 's gain/loss on asset sales?
Lumexa Imaging Holdings, Inc. (LMRI) reported gain/loss on asset sales of -$137K in Q1 2026.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.